Clinical trial
Phase IV, Open-labelled, Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) Vaccine
NCT03281174 is registered in ClinicalTrials.gov with Sinovac Biotech Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase IV, Open-labelled, Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) Vaccine
- Lead sponsor
- Sinovac Biotech Co., Ltd
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 20, 2017
- Completion date
- May 21, 2017
- Enrollment
- 343 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.